Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat

被引：0
|
作者：
Chuan Li
Guillaume Mousseau
Susana T. Valente
机构：
[1] The Scripps Research Institute,Department of Immunology and Microbiology
来源：
Epigenetics & Chromatin | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
    Li, Chuan
    Mousseau, Guillaume
    Valente, Susana T.
    EPIGENETICS & CHROMATIN, 2019, 12 (1)
  • [2] The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
    Mousseau, Guillaume
    Kessing, Cari F.
    Fromentin, Remi
    Trautmann, Lydie
    Chomont, Nicolas
    Valente, Susana T.
    MBIO, 2015, 6 (04):
  • [3] Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A
    Rice, Andrew P.
    MBIO, 2019, 10 (04):
  • [4] Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat
    Mediouni, Sonia
    Chinthalapudi, Krishna
    Ekka, Mary K.
    Usui, Ippei
    Jablonski, Joseph A.
    Clementz, Mark A.
    Mousseau, Guillaume
    Nowak, Jason
    Macherla, Venkat R.
    Beverage, Jacob N.
    Esquenazi, Eduardo
    Baran, Phil
    de Vera, Ian Mitchelle S.
    Kojetin, Douglas
    Loret, Erwann P.
    Nettles, Kendall
    Maiti, Souvik
    Izard, Tina
    Valente, Susana T.
    MBIO, 2019, 10 (01):
  • [5] Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription
    Mousseau, Guillaume
    Aneja, Rachna
    Clementz, Mark A.
    Mediouni, Sonia
    Lima, Noemia S.
    Haregot, Alexander
    Kessing, Cari F.
    Jablonski, Joseph A.
    Thenin-Houssier, Suzie
    Nagarsheth, Nisha
    Trautmann, Lydie
    Valente, Susana T.
    MBIO, 2019, 10 (04):
  • [6] Didehydro-Cortistatin A Inhibits HIV-1 Tat Mediated Neuroinflammation and Prevents Potentiation of Cocaine Reward in Tat Transgenic Mice
    Mediouni, Sonia
    Jablonski, Joseph
    Paris, Jason J.
    Clementz, Mark A.
    Thenin-Houssier, Suzie
    McLaughlin, Jay P.
    Valente, Susana T.
    CURRENT HIV RESEARCH, 2015, 13 (01) : 64 - 79
  • [7] In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock'' Strategy for HIV-1 Treatment
    Kessing, Cari F.
    Nixon, Christopher C.
    Li, Chuan
    Tsai, Perry
    Takata, Hiroshi
    Mousseau, Guillaume
    Ho, Phong T.
    Honeycutt, Jenna B.
    Fallahi, Mohammad
    Trautmann, Lydie
    Garcia, J. Victor
    Valente, Susana T.
    CELL REPORTS, 2017, 21 (03): : 600 - 611
  • [8] INHIBITION OF TAT-ACTIVATED, HIV-1 LONG TERMINAL REPEAT-MEDIATED GENE-EXPRESSION BY GLUCOCORTICOIDS
    MITRA, D
    SIKDER, S
    LAURENCE, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (11) : 1055 - 1056
  • [9] FUNCTIONAL DOMAINS REQUIRED FOR TAT-INDUCED TRANSCRIPTIONAL ACTIVATION OF THE HIV-1 LONG TERMINAL REPEAT
    GARCIA, JA
    HARRICH, D
    PEARSON, L
    MITSUYASU, R
    GAYNOR, RB
    EMBO JOURNAL, 1988, 7 (10): : 3143 - 3147
  • [10] Transcriptional and methylation outcomes of didehydro-cortistatin A use in HIV-1-infected CD4+ T cells
    Mori, Luisa P.
    Corley, Michael J.
    Mcauley, Andrew
    Pang, Alina
    Venables, Thomas
    Ndhlovu, Lishomwa C.
    Pipkin, Matthew E.
    Valente, Susana
    LIFE SCIENCE ALLIANCE, 2024, 7 (10)
12345